Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. FDA approves first drug to treat GVHD

    ... Ibrutinib Becomes First FDA-Approved Drug for Chronic Graft-Versus-Host Disease Article Source:  ...

    Article last updated 08/29/2017 - 7:55am.

  2. New positive results for GVHD treatment

    ... Link:  Ibrutinib Relieves Chronic Graft-Versus-Host Disease Symptoms Article ...

    Article last updated 01/12/2017 - 11:10am.

  3. Drug reduces acute GVHD in unrelated HSCTs

    ... a potentially effective combination to mitigate graft-versus-host disease (GVHD) in the setting of matched unrelated donor myeloablative ...

    Article last updated 02/27/2017 - 1:45pm.

  4. Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes

    ... respectively. The 100-day probability of Grade 2-4 acute graft-versus-host disease (GVHD) was 38%, and the 3-year probability of chronic GVHD was 28%. ...

    Research Article last updated 03/22/2017 - 9:24am.

  5. Discovered: Simple way to identify GVHD risks

    ... who received a bone marrow transplant will develop graft-versus-host disease, a common and often lethal complication, according to a study published ...

    Article last updated 02/09/2017 - 3:00pm.

  6. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia

    ... and mortality from graft failure and complications of graft-versus-host disease (GVHD) have limited enthusiasm for this approach. Here, we employed ...

    Research Article last updated 01/24/2017 - 10:04am.

  7. Strong results for SAA patients at Johns Hopkins

    ... 16 aplastic anemia patients free of disease after bone marrow transplant and chemo ... a year after their transplant, three developed mild graft-versus-host disease (GVHD) , a common complication of bone marrow ...

    Article last updated 02/07/2017 - 11:05am.

  8. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant

    ... had an increased cumulative incidence of grades II-IV acute graft-versus-host disease (aGVHD) (30.3 vs. 1.5%, P < 0.001), grades III-IV aGVHD (10.1 vs. ...

    Research Article last updated 02/03/2017 - 9:40am.

  9. A Comparison of Outcomes for Cord Blood Transplant and Unrelated Bone Marrow Transplant in Adult Aplastic Anemia

    ... [CI], .32 to .94; P = .029), adjusted for age and graft-versus-host disease (GVHD) prophylaxis, which were other associated factors. Mortality ...

    Research Article last updated 08/15/2016 - 1:06pm.

  10. Recent developments in bone marrow transplants

    ... prior to allogeneic HSCT significantly increased risk for graft-versus-host disease (GVHD)–related mortality in adults with T-cell leukemia/lymphoma. ...

    Article last updated 11/16/2016 - 2:56pm.